Kala Pharmaceuticals, Inc. (KALA) Social Stream



Kala Pharmaceuticals, Inc. (KALA): $0.34

0.00 (0.71%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Kala Pharmaceuticals Inc (KALA) Price Targets From Analysts

Use the tables below to see what analysts covering Kala Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-29 7 $43 $3.75 $14.458 $1.31 1003.66%
2021-11-16 7 $16 $2.5 $7.75 $1.31 491.6%
2021-12-15 7 $9 $2.5 $6.083 $1.31 364.35%
2022-03-09 7 $9 $2.5 $5.916 $1.31 351.6%
2022-03-30 7 $6 $1.75 $4.458 $1.31 240.31%

The Trend in the Analyst Price Target


Over the past 33 weeks, KALA's average price target has gone down $8.87.

Over the past 51 weeks, KALA's average upside potential has been 358.4%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 4 49 10.0 21.330 7.57 181.77%
2021-06-26 4 49 10.0 20.330 6.04 236.59%
2021-08-01 4 49 8.0 19.500 3.45 465.22%
2021-11-16 7 16 2.5 7.750 2.16 258.8%
2022-03-09 7 9 2.5 5.916 1.13 423.54%

KALA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.14 4 0 2 1 1 7

The Trend in the Broker Recommendations


Over the past 24 months, KALA's average broker recommendation rating worsened by 0.67.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • KALA has a lower variance in analysts' estimates than -470.77% of all US stocks.
  • In terms of how Kala Pharmaceuticals Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 567.23% of that group.
  • Kala Pharmaceuticals Inc's average analyst price target is higher than 35.63% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Kala Pharmaceuticals Inc's number of analysts covering the stock is higher than 518.22% of them.

In the Pharmaceutical Products industry, JANX, IVA, and ITRM are the three stocks most similar to Kala Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding KALA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4191 seconds.